Vilon: Dosage, Protocol, and Research Guide
Immunomodulating dipeptide for immune system regulation
Mechanism
Regulates immune cell differentiation, normalizes cytokine production, enhances immune response without overstimulation
Protocol at a glance
| Starting dose | 10mg |
|---|---|
| Maintenance dose | 10-20mg |
| Maximum dose | 20mg |
| Frequency | Daily |
| Typical duration | 20 days |
| Route | Sublingual/Oral |
| Injection site | N/A |
| Timing | Morning |
Side effects
- Minimal - very well tolerated
Contraindications
- Active autoimmune diseases
Protocol notes
- Gentle immune modulator
- Helps with chronic infections
- May improve cancer immunity
- Synthetic dipeptide (Lys-Glu)
- Part of Khavinson collection
Frequently asked questions
What is Vilon and how does it work?
Vilon is a synthetic immunomodulating dipeptide composed of lysine and glutamic acid (Lys-Glu). It functions as a bioregulator that regulates immune cell differentiation and normalizes cytokine production, enhancing immune response without causing overstimulation. Unlike broad immune boosters, Vilon achieves balance—supporting healthy immune regulation rather than simple activation. It is part of the Khavinson collection of peptide bioregulators and is administered sublingually or orally.
Is Vilon legal?
Vilon is a research peptide not approved by the FDA for human use. Its legal status varies by jurisdiction—some countries permit its sale for research purposes only, while others restrict it. Before purchase or use, verify local regulations and ensure any source is reputable. For research purposes only — not FDA-approved for human use. Consult a licensed physician before use.
What are the side effects of Vilon?
Vilon is reported to be minimal and very well tolerated with side effects rarely observed. The primary contraindication is active autoimmune disease, where immune modulation could theoretically worsen existing conditions. Anyone with autoimmune disorders should consult a licensed physician before use. No serious adverse events are documented in the literature, though individual responses may vary.
How do you dose Vilon?
Vilon dosing begins with a starting dose of 10mg daily, taken sublingually or orally in the morning. The maintenance dose ranges from 10–20mg daily. Treatment is typically structured as a 20-day cycle. The morning timing is chosen to align with natural immune cell activity rhythms. Always consult a healthcare provider to determine appropriate dosing for individual needs.
Can you cycle Vilon?
Vilon is designed as a 20-day treatment cycle, suggesting a discontinuous protocol rather than continuous daily use. After completing a 20-day cycle, a break is typically recommended before repeating. Cycling allows the body's immune system to respond to the modulation without sustained exposure. Research on optimal cycling intervals for Vilon remains limited, so personalization with a healthcare provider is advised.
Can you stack Vilon with other peptides?
Vilon may be stacked with complementary peptides, though research on specific combinations remains limited. When stacking multiple bioregulators or peptides, consider their mechanisms: Vilon regulates immune response without overstimulation, so pairing it with peptides that support different physiological systems (e.g., musculoskeletal, cognitive) is theoretically more balanced than combining multiple immune-focused compounds. Always consult a healthcare provider before combining multiple peptides.
What should I expect when taking Vilon?
Individual responses to Vilon vary. Because it works through subtle immune modulation rather than acute stimulation, many users report gradual improvements in recovery from minor illnesses, reduced inflammation markers, or improved baseline energy over the 20-day cycle. Some experience no obvious subjective sensation. Objective changes (lab markers, infection frequency, energy) typically emerge by mid-to-late cycle rather than immediately. Expectations should be calibrated to immune health support rather than dramatic acute effects.
Are there lab markers to monitor while taking Vilon?
Because Vilon influences cytokine production and immune cell function, relevant lab markers include inflammatory cytokines (IL-6, TNF-α), immune cell counts (T cell and B cell subsets), and general inflammation markers (CRP). Some practitioners also monitor white blood cell count and differential to assess immune cell differentiation. Research on specific biomarkers most sensitive to Vilon's effects remains limited. A healthcare provider can recommend individualized monitoring based on baseline health status and treatment goals.
More Bioregulators peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.